Compounds > ribavirin
Page last updated: 2024-08-16

ribavirin and Cardiac Diseases

ribavirin has been researched along with Cardiac Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bronte, F; Calvaruso, V; D'Ambrosio, R; Di Marco, V; Forni, G; Lanza, AG; Poggiali, E; Saracco, G1
De Vincentiis, L; Durante-Mangoni, E; Iossa, D; Pinto, D; Ragone, E; Utili, R1
Albrecht, JK; Bloomer, JR; Boparai, N; Brass, CA; Brown, KA; Galler, GW; Ghalib, RH; Herrine, SK; Jiang, R; King, JW; McCone, J; McHutchison, JG; Melia, MT; Muir, AJ; Mullen, KD; Noviello, S; Nunes, FA; Ravendhran, N; Shiffman, ML; Sulkowski, MS1
Cheson, BD; Grem, JL; Hawkins, MJ; King, SA; Rubinstein, L; Shoemaker, DD1
Edelson, PJ; Laufer, DA1

Reviews

1 review(s) available for ribavirin and Cardiac Diseases

ArticleYear
Clinical toxicity associated with tiazofurin.
    Investigational new drugs, 1990, Volume: 8, Issue:2

    Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Evaluation; Female; Heart Diseases; Humans; Infusions, Intravenous; Leukopenia; Male; Nausea; Neoplasms; Ribavirin; Ribonucleosides; Ulcer; Vomiting

1990

Other Studies

4 other study(ies) available for ribavirin and Cardiac Diseases

ArticleYear
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:6

    Topics: Adult; Antiviral Agents; beta-Thalassemia; Drug Therapy, Combination; Female; Heart Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Italy; Liver Cirrhosis; Logistic Models; Male; Multivariate Analysis; Polymorphism, Single Nucleotide; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load

2016
Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011, Volume: 43, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Disease Progression; Echocardiography; Electrocardiography; Female; Genotype; Heart Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Troponin I

2011
Racial differences in hepatitis C treatment eligibility.
    Hepatology (Baltimore, Md.), 2011, Volume: 54, Issue:1

    Topics: Adult; Alcoholism; Antiviral Agents; Black People; Diabetes Complications; Eligibility Determination; Female; Heart Diseases; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Mass Screening; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Retrospective Studies; Ribavirin; Substance-Related Disorders; Treatment Outcome; United States; White People

2011
Respiratory syncytial virus infection and cardiopulmonary disease.
    Pediatric annals, 1987, Volume: 16, Issue:8

    Topics: Child; Child, Preschool; Chlamydia Infections; Cross Infection; Diagnosis, Differential; Heart Diseases; Hospitalization; Humans; Infant; Lung; Oxygen; Radiography; Respiratory Syncytial Viruses; Respiratory Tract Infections; Respirovirus Infections; Ribavirin

1987